• Walter Flamenbaum, M.D.

    Chief Executive Officer

Walter Flamenbaum, M.D., Chief Executive Officer

Prior to being appointed the Chief Executive Officer of AgenTus Therapeutics Walter Flamenbaum, M.D. has held a number of positions in healthcare. He is a board member of Stuart Pharmaceuticals since its inception in 2017. At present he is on the board of OSE Pharma, a French biotechnology company, and previously served on the board of BioMotiv, a US investment company. He has also been a board member of several US-based and international healthcare companies.

Walter Flamenbaum

Dr. Flamenbaum is a Managing Director of The Channel Group since 2014. Prior to that he was the Founding Partner of Paul Capital Healthcare Funds, which has invested over $1 billion in forty investments, and was a Partner Emeritus at Paul Capital. He led the development and refinement of its investment strategy, processes and techniques, as well as actively participating in the majority of the Fund’s investments, including roles in sourcing, negotiating, structuring and other activities.  Dr. Flamenbaum’s broad based medical knowledge and investment experience provided the Fund with a unique resource for healthcare royalty and revenue investing.  He was primarily responsible for the development of the diverse team of healthcare and financial investment professionals, allowing for the Fund’s development and successes.

Dr. Flamenbaum has more than 40 years of healthcare experience, including the development and evaluation of pharmaceutical and biotechnology based-drugs, medical devices and diagnostics. During the 10 years prior to joining Paul Capital Partners in 1999, he had extensive experience in the licensing of healthcare product-related intellectual properties and the assessment of the develop of healthcare and in healthcare investing opportunities.  Prior to Paul Capital he founded a contract research organization, started a biomedical company, and had senior management responsibilities in a biotechnology company.  These activities provided him with a broad and well developed base in healthcare product development and commercialization.

He has been board certified in internal medicine, nephrology and clinical pharmacology and was a professor of medicine at the Mt. Sinai School of Medicine and Tufts University School of Medicine. Dr. Flamenbaum served in the U.S. Army at the Walter Reed Army Institute of Research and the Walter Reed Army Medical Center from 1970 until 1976.  He completed his training in internal medicine at the Hospital of the University of Pennsylvania, and his fellowship in nephrology at the Peter Bent Brigham Hospital. He earned his M.D. from Columbia University’s College of Physicians & Surgeons and his B.A. from Washington & Jefferson College.